Physician and former U.S. Food and Drug Administration Commissioner Dr. David Kessler reportedly might testify in Risperdal lawsuit trials that may be held at a Philadelphia trial court. Kessler had submitted documents to the court consistent with the testimony he would have given in 2012 on behalf of the plaintiffs. But a defendant, pharmaceutical corporation Johnson & Johnson, settled several Risperdal lawsuits before trial back then.
Transvaginal mesh bellwether trial scheduled
There is a new development in transvaginal mesh litigation. A significant trial is scheduled to begin in March.
Transvaginal mesh bellwether trial scheduled
There is a new development in transvaginal mesh litigation. A significant trial is scheduled to begin in March.
Zoloft not studied solely for birth defects risk
As if the alleged birth defects risk is not enough, a British medical journal published a case study suggesting that hepatitis may be related to the use of Zoloft (sertraline), a selective serotonin reuptake inhibitor, or SSRI, antidepressant.
Zoloft not studied solely for birth defects risk
As if the alleged birth defects risk is not enough, a British medical journal published a case study suggesting that hepatitis may be related to the use of Zoloft (sertraline), a selective serotonin reuptake inhibitor, or SSRI, antidepressant.
Propecia injury attracts international interest
The study of sexual dysfunction linked to the use of the male pattern hair loss drug Propecia has been spreading globally, according to the growing number of nations whose surfers have pointed their web browsers at a U.S.-based source of information. While this has been going on, a growing number of injured patients have filed Propecia lawsuits.
Propecia injury attracts international interest
The study of sexual dysfunction linked to the use of the male pattern hair loss drug Propecia has been spreading globally, according to the growing number of nations whose surfers have pointed their web browsers at a U.S.-based source of information. While this has been going on, a growing number of injured patients have filed Propecia lawsuits.
Let's hope Actos, Januvia history is not repeated
The U.S. Food and Drug Administration on Jan. 8 approved another diabetes drug. One should hope that patients and their physicians will not be blindsided with serious unforeseen increased risks of using the drug, which has happened with diabetes drugs before.
Let's hope Actos, Januvia history is not repeated
The U.S. Food and Drug Administration on Jan. 8 approved another diabetes drug. One should hope that patients and their physicians will not be blindsided with serious unforeseen increased risks of using the drug, which has happened with diabetes drugs before.
FDA tightens acetaminophen recommendations
Reaffirming the link between taking too much acetaminophen and developing liver disease, the U.S. Food and Drug Administration on Jan. 14 escalated its recommendations on the use of the pain reliever.
